Colorectal cancer 2000: Education and screening are essential if outcomes are to improve

Postgraduate Medicine

Volumn 107, Issue 5, 2000, Pages 96-107

  Kuwada, Scott K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARCINOEMBRYONIC ANTIGEN; CELECOXIB; CYCLOOXYGENASE 2; FLUOROURACIL; LEVAMISOLE; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER STAGING; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CONFERENCE PAPER; EARLY DIAGNOSIS; FAMILY HISTORY; HUMAN; POLYMERASE CHAIN REACTION;

EID: 0034193956     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.5.1.1059     Document Type: Conference Paper

References (30)

1. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin 1998;48(1):6-29
2. American Institute for Cancer Research. Meat, poultry, fish and eggs. In: Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 1997
3. Potter JD, Slattery ML, Bostick RM, et al. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993;15(2):499-545
4. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999;106(5):574-82
5. Franceschi S, La Vecchia C. Colorectal cancer and hormone replacement therapy: an unexpected finding. Eur J Cancer Prev 1998; 7(6):427-38
6. Hebert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 1998;7(8):653-9
7. Troisi R, Schairer C, Chow WH, et al. A prospective study of menopausal hormones and risk of colorectal cancer. Cancer Causes Control 1997;8(2):130-8
8. Newcomb PA, Storer BE. Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 1995;87(14):1067-71 [Erratum, J Natl Cancer Inst 1995;87(18):1416]
9. Grodstein F, Martinez ME, Platz EA, et al. Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 1998;128(9):705-121
10. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998;129(7):517-24
11. Holt PR. Dairy foods and prevention of colon cancer: human studies. J Am Coll Nutr 1999;18(Suppl 5):379-91S
12. Rosenberg L, Palmer JR, Zauber AG, et al. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 1991;83(5):355-8
13. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333(10):609-14
14. Giovannucci E, Rimm EB, Stampfer MJ, et al. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121(4):241-6
15. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325(23):1593-6
16. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. N Engl J Med 1993;328(19): 1365-71 [Erratum, N Engl J Med 1993;329(9):672]
17. Friedman GD, Collen MF, Fireman BH. Multiphasic Health Checkup Evaluation: a 16-year follow-up. J Chronic Dis 1986; 39(6):453-63
18. Selby JV, Friedman GD, Quesenberry CP Jr, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326(10):653-7
19. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84(20):1572-5
20. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329(27):1977-81
21. Fuchs CS, Giovannucci EL, Colditz GA. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331(25):1669-74
22. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996;334(2):82-7
23. Khandekar S, Kuwada SK, Khullar S, et al. The frequency of high-risk familial colorectal cancer. Gastroenterology 1988; 114:621A
24. Fearon ER, Dang CV. Cancer genetics: tumor suppressor meets oncogene. Curr Biol 1999;9(2):R62-5
25. Behrens J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev 1999;18(1):15-30
26. Whitehouse A, Meredith DM, Markham AF. DNA mismatch repair genes and their association with colorectal cancer. Int J Mol Med 1998;1(2):469-74
27. Jiricny J. Eukaryotic mismatch repair: an update. Mutat Res 1998;409(3):107-21
28. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997;336(12):823-7
29. Fleming ID, Cooper JS, Henson DE, et al, eds. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 1997:83-90
30. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339(4):223-8